DDIT4 and type 2 diabetes mellitus: Overall, REDD1 stimulates atypical NF-κB activation-mediated proinflammatory cytokine production, thereby contributing to T2D through inhibition of an insulin-driven IRS−PI3K−Akt signaling axis6.